A total of 51 patients underwent DMD treatment, including 22 cases on interferon β (IFN-β), one using glatiramer acetate (GA), 13 using dimethyl fumarate (DMF), 10 using fingolimod (FTY), two using NTZ, two using siponimod, and one using OMA. This evidence concerns the gene IFNB1 and Duchenne muscular dystrophy.